Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

446

HTML

3207

Figures (1-2)

264

Tables (1-5)

252

Sum=4169

Oct 15, 2012 (publication date) through Feb 6, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Oncol. Oct 15, 2012; 4(10): 207-215
Published online Oct 15, 2012. doi: 10.4251/wjgo.v4.i10.207

Table 3 Patient outcomes n (%)

Recurrence status (n= 169)
Recurred	124 (73.3)
No recurrence	45 (26.6)
Recurrence location (n = 124)
Local	21 (16.9)
Distant	66 (53.2)
Local and distant	7 (5.6)
Unknown	30 (24.2)
Overall survival time (mo)	15.1 (8.0-33.5)¹
Time to recurrence (mo)	9.8 (5.1-21.1)¹
Disease-related survival status (n = 169)
Death from disease	104 (62.5)
Death from other causes	19 (11.2)
Alive with disease	21 (12.4)
Alive with no disease	25 (14.8)

¹Median (interquartile range).

Citation: Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215
URL: https://www.wjgnet.com/1948-5204/full/v4/i10/207.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i10.207